Innovations in Small Molecule, Biopharmaceutical, and Liquid Biopsy Platforms

Innovations in Small Molecule, Biopharmaceutical, and Liquid Biopsy Platforms

RELEASE DATE
16-Aug-2019
REGION
Global
Research Code: D759-00-0B-00-00
SKU: HC03206-GL-TA_23506

$950.00

Special Price $712.50 save 25 %

In stock
SKU
HC03206-GL-TA_23506

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises innovations in small molecule, biopharmaceutical and liquid biopsy platforms. Some of the technologies profiled include advances related to nerve-on-a-chip technology, use of artificial intelligence for drug discovery, biomarker identification, immunotherapies, mRNA vaccines, cell therapy, drug delivery, and liquid biopsy methods. The TOE also provides a comprehensive listing of key innovators in this space.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Small molecule, biopharma, biologic, axosim, nerve-on-a-chip, denali, brain delivery, yumanity, integrated discovery, verge, genomics, artificial intelligence, drug discovery, precision therapy, liquid biopsy, immuno-oncology, anti-CD38, immunotherapy, mRNA vaccine, RCT, cell therapy, respiratory therapy, muscular dystrophy, multiomics, genetic screening, frequency therapeutics, CAR-T

Table of Contents

Recent Advancements in Biopharmaceutical, Small Molecule, and Liquid Biopsy Technologies

  • AxoSim
  • AxoSim
  • Denali Therapeutics
  • Denali Therapeutics
  • Yumanity Therapeutics
  • Yumanity Therapeutics
  • Verge Genomics
  • Verge Genomics
  • QurAlis
  • QurAlis
  • I-Mab Biopharma (Shanghai) Co. Ltd.
  • I-Mab Biopharma (Shanghai) Co. Ltd.
  • Genexine Inc.
  • Genexine Inc.
  • eTheRNA Immunotherapies NV
  • eTheRNA Immunotherapies NV
  • Rubius Therapeutics Inc.
  • Rubius Therapeutics Inc.
  • Rakuten Medical Inc.
  • Rakuten Medical Inc.
  • Medigene AG
  • Medigene AG
  • Ziopharm Oncology Inc.
  • Ziopharm Oncology Inc.
  • Atara Biotherapeutics Inc.
  • Atara Biotherapeutics Inc.
  • Celldex Therapeutics Inc.
  • Celldex Therapeutics Inc.
  • Breath Therapeutics
  • Breath Therapeutics
  • Hospital for Sick Children
  • Hospital for Sick Children
  • Freenome
  • Freenome
  • Invitae
  • Invitae
  • TScan Therapeutics
  • TScan Therapeutics
  • Myovant Sciences
  • Myovant Sciences
  • Frequency Therapeutics
  • Frequency TherapeuticsN
  • PACT Pharma
  • PACT Pharma
  • Myriad Genetics, Inc.
  • Myriad Genetics, Inc.
  • Eli Lilly
  • Eli Lilly
  • Exact Sciences
  • Exact Sciences
  • Personal Genome Diagnostics
  • Personal Genome Diagnostics

Appendix

  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Key Contacts
  • Your F&S Thought Leader
Related Research
This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises innovations in small molecule, biopharmaceutical and liquid biopsy platforms. Some of the technologies profiled include advances related to nerve-on-a-chip technology, use of artificial intelligence for drug discovery, biomarker identification, immunotherapies, mRNA vaccines, cell therapy, drug delivery, and liquid biopsy methods. The TOE also provides a comprehensive listing of key innovators in this space. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Small molecule, biopharma, biologic, axosim, nerve-on-a-chip, denali, brain delivery, yumanity, integrated discovery, verge, genomics, artificial intelligence, drug discovery, precision therapy, liquid biopsy, immuno-oncology, anti-CD38, immunotherapy, mRNA vaccine, RCT, cell therapy, respiratory therapy, muscular dystrophy, multiomics, genetic screening, frequency therapeutics, CAR-T
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-0B-00-00
Is Prebook No
Ti Codes D759